Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors

Miguel Gallego1, Xavier Pomares, Mateu Espasa

  • 1Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, Spain. mgallego@tauli.cat.

Abstract

Insights

In severe chronic obstructive pulmonary disease (COPD), bronchiectasis and antibiotic use increase Pseudomonas aeruginosa infection risk. Over 10% of patients experience chronic P. aeruginosa colonization, independent of bronchiectasis.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Microbiology

Background:

  • Patients with severe chronic obstructive pulmonary disease (COPD) face a higher risk of Pseudomonas aeruginosa infections.
  • The role of bronchiectasis in P. aeruginosa infection and chronic colonization in COPD is not well understood.

Purpose of the Study:

  • To determine the prevalence and risk factors for P. aeruginosa recovery from sputum in severe COPD outpatients.
  • To characterize P. aeruginosa isolates using pulsed-field gel electrophoresis (PFGE).
  • To investigate the influence of bronchiectasis on chronic P. aeruginosa colonization.

Main Methods:

  • A case-cohort study involving 118 severe COPD patients followed for one year.
  • High-resolution CT scans for bronchiectasis assessment and sputum cultures during exacerbation and stability.
  • P. aeruginosa isolates were genotyped by PFGE, and risk factors were analyzed using multivariate analysis.

Main Results:

  • P. aeruginosa was isolated in 34.7% of patients; 12.2% met criteria for chronic colonization.
  • The extent of bronchiectasis (OR 9.8) and antibiotic courses (OR 1.7) were independent risk factors for P. aeruginosa isolation.
  • Chronic colonization was not associated with bronchiectasis, but isolates showed clonal persistence and harbored multidrug-resistant strains.

Conclusions:

  • Bronchiectasis extent and antibiotic exposure are key risk factors for P. aeruginosa isolation in severe COPD.
  • Over 10% of severe COPD patients experience chronic P. aeruginosa colonization with clonal persistence.
  • Chronic colonization by P. aeruginosa occurs independently of bronchiectasis in this patient group.

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
29
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
22
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
32
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K